Introduction
Multiple synchronous cancers in the same organ or in various organs are rather unusual. Sometimes this condition is diagnosed during the staging process of the tumour, by postoperative histology of a resected organ, but it is mostly identified by autopsy. During the diagnostic procedure involving the patient with suspicious multiple tumours, a dilemma appears relative to the precise staging of each of all probable tumours in a patient suitable only for symptomatic therapy.
A case of synchronous triple tumours is presented in which noninvasive diagnostic procedures were performed and suspicion of triple primary cancer was established. The patient refused invasive diagnostics and left the hospital. Fortunately, the course of the disease was rather favorable, and none of the three tumours caused symptoms requiring urgent invasive diagnostics or attempts at any specific therapies. Despite three disseminated carcinomas, the patient survived at home, i.e. without specific or symptomatic therapy needing hospitalization, for 19 months after the diagnosis of two lung tumours and a kidney tumour.
Case report
A 78-year-old man with hypertension and angina pectoris was brought to the hospital due to syncope without convulsions in June 2005. At the time of admittance he had no fever but a dry cough. Laboratory tests indicated anemia (Hb 9.2 g/dL), leucocytosis (WBC 16.5 x 10 3 /μL), hypokalemia (potassium 3.4 mmol/ L), slightly elevated BUN and creatinine, and low serum iron (2.7 μmol/L).
A CT scan of the brain showed diffuse atrophy without signs of metastasis. On the chest X-ray, tumours infiltrating in both upper lobes were visible. The lesion on the left side was excavated ( Figure  1) . A CT scan of the thorax and upper abdomen showed -in addition to tumour lesions in the left and right lung -also a tumour-enlarged right kidney ( Figure 2 ). The conclusion after the im- aging procedures was the probability of three synchronous primary tumours: a tumour in the right upper lobe infiltrating the mediastinum, a tumour in the left upper lobe with metastases to hilar and mediastinal lymph nodes, and a tumour in the right kidney.
The patient did not agree to further invasive diagnostics for verification of the tumours, and despite some persuasion he left the hospital with advice for a urological examination.
By the end of December 2006, the patient was admitted bedridden, dehydrated, somnolent, with respiratory insufficiency, anisocoria and anamnesis of frequent vomiting during the previous few days. Laboratory tests showed high inflammatory parameters (CRP 97.2 mg/ dL, WBC 16.6 x 10 3 /μL), and elevated BUN (50.8 mmol urea /L) and creatinine (149 μmol/L), but there was no anemia (hemoglobin was currently 15.9 g/dL).
A brain CT showed cerebral atrophy and a coliquated round lesion in the right occipital region without surrounding oedema (Figure 3) . On the chest X-ray, the known tumours of the upper lobes and diffuse infiltrates in both lungs appeared (Figure 4) .
The patient received antibiotics and parenteral hydration, and died four days after admittance.
The autopsy revealed the excavated tumour of the left upper lobe, 7 cm in diameter, infiltrating the left main bronchus, to be a necrotizing small-cell carcinoma with metastases to ipsilateral hilar and ipsilateral mediastinal lymph nodes, and with necrotizing spleen metastasis of 3 cm.
The tumour of the right upper lobe, 10 cm in diameter, was also necrotizing. Due to enlarged and coliquated hilar and mediastinal lymph nodes, there was an impression of tuberculosis. But histology showed a necrotizing squamous cell carcinoma of the right lung and lymph nodes, and a necrotizing metastasis of the same histology was revealed in the right occipital region of the brain.
The right kidney was entirely transformed by a 13 cm tumour infiltrating the renal capsule and perirenal fat tissue. Histology revealed a necrotizing well differentiated clear-cell carcinoma with multiple metastases to both lungs.
All three primary tumours as well the metastases of the brain, spleen, right hilar and mediastinal lymph nodes, were necrotizing. The cause of death was bronchopneumonia.
Discussion
In patients with two or more tumour lesions detected in various organs, one reasons that it is a primary tumour with metastases, which is statistically most probable. Synchronous triple tumours are uncommon. In the annual reports of the Cancer Registry of Slovenia it is not possible to determine the number of patients with multiple cancers, since these are registered as different single tumours, i.e. cancer cases, irrespective of the number of patients. 1 So, a triple cancer would be registered three times, despite involving the same patient. In the literature it is difficult to obtain data on synchronous cancers. Hamada et al. 2 reported a gradual increase of triple primary cancers in Japan in the period 1994-1996. The incidence of triple cancers represented 0.81% of all autopsy cases reported.
There are interesting site combinations of triple cancers. The most frequently reported were all tumours in the same organ or organ system: lung, 3-9 digestive organs, [10] [11] [12] [13] and urogenital organs. [14] [15] [16] [17] [18] [19] Lung cancer appeared in combination with tumours of two various organs: urinary bladder and esophagus, 20 breast and stomach, 21 pancreas and duodenum, 22 and stomach and thyroid. 2 Kidney cancer was seen in combination with tumours of the liver and oral floor, 23 sigmoid colon and thyroid. 24 On PubMed one can find articles on synchronous triple tumours, for all successfully resected ones, but mostly published in Japanese without an English abstract. Therefore, the many cases of synchronous triple cancers established in Japan raise the possibility of the influence of atomic bomb radiation on cancer incidence. Hakada et al. 17 mentioned that there had been a patient with synchronous cancers of the kidney, urinary bladder and prostate exposed to the atomic bomb explosion in Hiroshima in 1945.
In our patient presented above, it is questionable whether the disease could have progressed otherwise, even with the patient's agreement to invasive diagnostics at the time of first admittance to the hospital. Probably one or both lung tumours could have been established by bronchoscopy. A needle aspiration biopsy under ultrasound guidance would have been necessary for verification of the kidney tumour. Had there been successful definition of all primary tu-mours, carefully dosed chemotherapy for lung cancer would parhaps have been applied. The kidney tumour would certainly not have responded to chemotherapy, and embolization of the renal artery would have been indicated, especially in the case of haematuria. Concerning the necrosis of all primary tumours and their metastases to the brain, spleen and thoracic lymph nodes, as established by the autopsy, chemotherapy would probably not have influenced survival, but certainly would have impaired the patient's quality of life. The patient decided on "wait and see" management and lived at home to the age of 80, thus saving the physicians the dilemma of performing invasive investigation and staging of the tumours. Considering that at the time of first admittance a lack of the possibility of effective therapy was already evident, even the objection to bronchoscopy could be considered reasonable.
In conclusion, in the case of synchronous triple cancers in an elderly patient the possibilities of effective therapy are limited. Therefore, invasive diagnostics and accurate staging may not be indicated in patients with bilateral advanced primary lung tumours. A "wait and see" decision can be quite a reasonable option.
